Raltegravir (potassium salt)

Raltegravir (potassium salt)

CAT N°: 16071
Price:

From 74.00 62.90

Raltegravir is an orally bioavailable inhibitor of HIV-1 integrase (IC50 = 15 nM in a strand transfer assay).{26192} It inhibits the spread of HIV-1IIIb infection in MT-4 cell culture with 95% cell culture inhibitory concentration (CIC95) values of 19 and 31 nM in medium containing 10% heat-inactivated fetal bovine serum (FBS) or 50% normal human serum, respectively. Formulations containing raltegravir have been used in combination therapy in the treatment of HIV-1 infection.

Territorial Availability: Available through Bertin Technologies only in France

  • Synonyms
    • N-[(4-fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-methyl-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxo-4-pyrimidinecarboxamide, monopotassium salt
  • Correlated keywords
    • 518048-05-0 925701-?81-?1 antiviral inhibitors infectious diseases anti viral anti-viral inhibits inhibitions potent HIV integrase selective oral orally bioavailable metabolized uridine diphosphates glucuronosyltransferase 1A1 salts potassium MKs 0518 MK0518 MK-0518 HIV-1 HIV1 one isentress K K+
  • Product Overview:
    Raltegravir is an orally bioavailable inhibitor of HIV-1 integrase (IC50 = 15 nM in a strand transfer assay).{26192} It inhibits the spread of HIV-1IIIb infection in MT-4 cell culture with 95% cell culture inhibitory concentration (CIC95) values of 19 and 31 nM in medium containing 10% heat-inactivated fetal bovine serum (FBS) or 50% normal human serum, respectively. Formulations containing raltegravir have been used in combination therapy in the treatment of HIV-1 infection.

We also advise you